Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Shutterstock
SSTK
$219M
| $1.91M | ﹤0.01% |
44,589
-3,335
| -7% | -$134K |
|
|
FSP
3027
Franklin Street Properties
FSP
$46.8M
| $1.91M | ﹤0.01% |
223,088
+44,665
| +25% | +$384K |
|
3028
Artisan Partners
APAM
$3.02B
| $1.91M | ﹤0.01% |
58,959
+23,669
| +67% | +$683K |
|
|
ENDP
3029
PUT
DELISTED
Endo International plc
ENDP
| $1.9M | ﹤0.01% |
405,900
+381,000
| +1,530% | +$1.7M |
|
|
MDCO
3030
PUT
DELISTED
Medicines Co
MDCO
| $1.9M | ﹤0.01% |
22,400
+14,800
| +195% | +$987K |
|
3031
Tompkins Financial
TMP
$1.42B
| $1.9M | ﹤0.01% |
20,790
+6,906
| +50% | +$597K |
|
3032
CALL
Ovintiv
OVV
$16.4B
| $1.9M | ﹤0.01% |
81,015
-253,320
| -76% | -$5.42M |
|
|
TGI
3033
DELISTED
Triumph Group
TGI
| $1.9M | ﹤0.01% |
75,185
-163,574
| -69% | -$4.06M |
|
3034
PUT
Henry Schein
HSIC
$9.82B
| $1.9M | ﹤0.01% |
28,400
+26,800
| +1,675% | +$1.77M |
|
|
LADR
3035
Ladder Capital
LADR
$1.24B
| $1.89M | ﹤0.01% |
104,965
+23,630
| +29% | +$408K |
|
3036
CALL
Campbell Soup
CPB
$6.87B
| $1.89M | ﹤0.01% |
38,300
+14,300
| +60% | +$678K |
|
3037
PUT
Consolidated Edison
ED
$39.8B
| $1.89M | ﹤0.01% |
20,900
+20,000
| +2,222% | +$1.79M |
|
3038
PUT
Wabtec
WAB
$49.3B
| $1.89M | ﹤0.01% |
24,300
-6,200
| -20% | -$459K |
|
3039
PUT
Abercrombie & Fitch
ANF
$5B
| $1.89M | ﹤0.01% |
109,200
+28,900
| +36% | +$478K |
|
3040
Cohen & Steers
CNS
$4.3B
| $1.89M | ﹤0.01% |
30,073
+10,433
| +53% | +$660K |
|
3041
Edgewell Personal Care
EPC
$1.31B
| $1.89M | ﹤0.01% |
60,927
+3,979
| +7% | +$128K |
|
3042
CALL
Angi Inc
ANGI
$196M
| $1.89M | ﹤0.01% |
+22,250
| New | +$1.66M |
|
3043
PUT
GSK
GSK
$106B
| $1.88M | ﹤0.01% |
32,080
-19,520
| -38% | -$1.09M |
|
3044
Lakeland Financial Corp
LKFN
$1.53B
| $1.88M | ﹤0.01% |
38,499
+22,598
| +142% | +$1.05M |
|
3045
Vicor
VICR
$10.2B
| $1.88M | ﹤0.01% |
40,277
+3,355
| +9% | +$128K |
|
|
AVP
3046
CALL
DELISTED
Avon Products, Inc.
AVP
| $1.88M | ﹤0.01% |
333,900
-36,900
| -10% | -$171K |
|
3047
Cactus
WHD
$5.44B
| $1.88M | ﹤0.01% |
54,648
+13,183
| +32% | +$400K |
|
|
ZUO
3048
DELISTED
Zuora, Inc.
ZUO
| $1.88M | ﹤0.01% |
130,858
+50,204
| +62% | +$736K |
|
3049
PUT
RingCentral
RNG
$5.28B
| $1.87M | ﹤0.01% |
+11,100
| New | +$1.83M |
|
3050
CALL
Eastman Chemical
EMN
$8.42B
| $1.87M | ﹤0.01% |
23,600
-14,000
| -37% | -$1.08M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.